Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 6) *
The Medicines Company
(Name of Issuer)
Common Stock
(Title of Class of Securities)
(Title of Class of Securities)
584688105
(CUSIP Number)
December 31, 2011
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
(Page 1 of 11 Pages)
_____________
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No.
|
584688105
|
13G
|
Page 2 of 11 Pages
|
|
1.
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Deerfield Capital, L.P.
|
||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) o
(b) ý
|
|
|
3.
|
SEC USE ONLY
|
||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
|
6.
|
SHARED VOTING POWER
879,533 (1)
|
||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
||
|
8.
|
SHARED DISPOSITIVE POWER
879,533 (1)
|
||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
879,533 (1)
|
||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
¨
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.62%
|
||
|
12.
|
TYPE OF REPORTING PERSON*
PN
|
||
(1) Comprised of 879,533 shares of common stock held by Deerfield Partners, L.P.
|
CUSIP No.
|
584688105
|
13G
|
Page 3 of 11 Pages
|
|
1.
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Deerfield Partners, L.P.
|
||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) o
(b) ý
|
|
|
3.
|
SEC USE ONLY
|
||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
|
6.
|
SHARED VOTING POWER
879,533
|
||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
||
|
8.
|
SHARED DISPOSITIVE POWER
879,533
|
||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
879,533
|
||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
¨
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.62%
|
||
|
12.
|
TYPE OF REPORTING PERSON*
PN
|
||
|
CUSIP No.
|
584688105
|
13G
|
Page 4 of 11 Pages
|
|
1.
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Deerfield Management Company, L.P.
|
||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) o
(b) ý
|
|
|
3.
|
SEC USE ONLY
|
||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
|
6.
|
SHARED VOTING POWER
1,175,364 (2)
|
||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
||
|
8.
|
SHARED DISPOSITIVE POWER
1,175,364 (2)
|
||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,175,364 (2)
|
||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
¨
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.17%
|
||
|
12.
|
TYPE OF REPORTING PERSON*
PN
|
||
(2) Comprised of 1,175,364 shares of common stock held by Deerfield International Limited.
|
CUSIP No.
|
584688105
|
13G
|
Page 5 of 11 Pages
|
|
1.
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Deerfield International Limited
|
||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) o
(b) ý
|
|
|
3.
|
SEC USE ONLY
|
||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
|
||
|
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
|
6.
|
SHARED VOTING POWER
1,175,364
|
||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
||
|
8.
|
SHARED DISPOSITIVE POWER
1,175,364
|
||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,175,364
|
||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
¨
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.17%
|
||
|
12.
|
TYPE OF REPORTING PERSON*
CO
|
||
|
CUSIP No.
|
584688105
|
13G
|
Page 6 of 11 Pages
|
|
1.
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
James E. Flynn
|
||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) o
(b) ý
|
|
|
3.
|
SEC USE ONLY
|
||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
|
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
40,000
|
|
|
6.
|
SHARED VOTING POWER
2,054,897 (3)
|
||
|
7.
|
SOLE DISPOSITIVE POWER
40,000
|
||
|
8.
|
SHARED DISPOSITIVE POWER
2,054,897 (3)
|
||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,094,897
|
||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
¨
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.87%
|
||
|
12.
|
TYPE OF REPORTING PERSON*
IN
|
||
(3) Comprised of 879,533 shares of common stock held by Deerfield Partners, L.P. and 1,175,364 shares of common stock held by Deerfield International Limited.
|
CUSIP No.
|
584688105
|
13G
|
Page 7 of 11 Pages
|
| Item 1(a). | Name of Issuer: | |
|
The Medicines Company
|
||
| Item 1(b). | Address of Issuer's Principal Executive Offices: | |
|
8 Sylvan Way, Parsippany, New Jersey 07054
|
||
| Item 2(a). | Name of Person Filing: | |
|
James E. Flynn, Deerfield Capital, L.P., Deerfield Partners, L.P., Deerfield Management Company, L.P., Deerfield International Limited
|
||
| Item 2(b). | Address of Principal Business Office, or if None, Residence: | |
|
James E. Flynn, Deerfield Capital, L.P., Deerfield Partners, L.P.,
Deerfield Management Company, L.P., 780 Third
Avenue, 37th Floor, New York, NY 10017, Deerfield International Limited,
c/o Citi Hedge Fund Services (B.V.I.) Ltd., Bison Court, Columbus Centre,
P.O. Box 3460, Road Town, Tortola, D8, British Virgin Islands
|
||
| Item 2(c). | Citizenship: | |
|
James E. Flynn - United States citizen
Deerfield Capital, L.P., Deerfield Partners, L.P. and
Deerfield Management Company, L.P. - Delaware limited partnerships,
Deerfield International Limited- British Virgin Islands corporation
|
||
| Item 2(d). | Title of Class of Securities: | |
|
Common Stock
|
||
| Item 2(e). | CUSIP Number: | |
|
584688105
|
||
| Item 3. |
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
| (a) | o | Broker or dealer registered under Section 15 of the Exchange Act. | |
| (b) | o | Bank as defined in Section 3(a)(6) of the Exchange Act. | |
| (c) | o | Insurance company as defined in Section 3(a)(19) of the Exchange Act. | |
| (d) | o | Investment company registered under Section 8 of the Investment Company Act. | |
| (e) | o | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
| (f) | o | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); | |
| (g) | o | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
| (h) | o | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
| (i) | o | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; | |
| (j) | o |
A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
|
|
| (k) | o |
Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
|
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________
|
CUSIP No.
|
589889104
|
13G
|
Page 8 of 11 Pages
|
| Item 4. | Ownership. |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount beneficially owned**: | ||
|
Deerfield Capital, L.P. – 879,533 shares
Deerfield Partners, L.P. – 879,533 shares
Deerfield Management Company, L.P. – 1,175,364 shares
Deerfield International Limited – 1,175,364 shares
James E. Flynn – 2,094,897 shares
|
|||
| (b) | Percent of class**: | ||
|
Deerfield Capital, L.P. – 1.62%
Deerfield Partners, L.P. – 1.62%
Deerfield Management Company, L.P. – 2.17%
Deerfield International Limited – 2.17%
James E. Flynn – 3.87%
|
| (c) | Number of shares as to which such person has**: | ||||
|
Sole power to vote or to direct the vote:
|
James E. Flynn – 40,000 | ||||
| (i) |
All other Reporting Persons - 0
|
||||
| (ii) |
Shared power to vote or to direct the vote
|
Deerfield Capital, L.P. – 879,533
Deerfield Partners, L.P. – 879,533
Deerfield Management Company,
L.P. – 1,175,364
Deerfield International Limited – 1,175,364
James E. Flynn - 2,054,897
|
|||
| (iii) |
Sole power to dispose or to direct the disposition of
|
James E. Flynn – 40,000
|
|||
|
All other Reporting Persons - 0
|
|||||
| (iv) |
Shared power to dispose or to direct the disposition of
|
Deerfield Capital, L.P. – 879,533
Deerfield Partners, L.P. – 879,533
Deerfield Management Company,
L.P. – 1,175,364
Deerfield International Limited – 1,175,364
James E. Flynn - 2,054,897
|
|
CUSIP No.
|
589889104
|
13G
|
Page 9 of 11 Pages
|
**See footnotes on cover pages which are incorporated by reference herein.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following x.
|
|
|
|
Item 6.
|
Ownership of More Than Five Percent on Behalf of Another Person. |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to m
ore than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
|
|
N/A
|
|
CUSIP No.
|
589889104
|
13G
|
Page 10 of 11 Pages
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
|
|
N/A
|
|
Item 8.
|
Identification and Classification of Members of the Group. |
If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the identity of each member of the group.
|
|
See Exhibit B
|
|
Item 9.
|
Notice of Dissolution of Group. |
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
|
|
N/A
|
|
Item 10.
|
Certifications. |
"By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11."
|
|
|
Page 11 of 11 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
DEERFIELD CAPITAL, L.P.
|
||
|
By:
|
J.E. Flynn Capital LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
DEERFIELD PARTNERS, L.P.
|
||
|
By:
|
Deerfield Capital, L.P.
|
|
|
By:
|
J.E. Flynn Capital LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
|
Darren Levine, Attorney-In-Fact
|
|
|
DEERFIELD MANAGEMENT COMPANY, L.P.
|
||
|
By:
|
Flynn Management LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
DEERFIELD INTERNATIONAL LIMITED
|
||
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
JAMES E. FLYNN
|
||
|
/s/ Darren Levine
|
||
|
Darren Levine, Attorney-In-Fact
|
||
Date: February 14, 2012
Exhibit List
Exhibit A . Joint Filing Agreement.
Exhibit B. Item 8 Statement.
Exhibit C. Power of Attorney(1).
(1)Previously filed as Exhibit C to the Schedule 13G for Antares Pharma, Inc. filed with the Commission on February 14, 2012 by Deerfield Capital, L.P., Deerfield Special Situations Fund, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund International Limited and James E. Flynn.
Exhibit A
The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Common Stock of The Medicines Company shall be filed on behalf of the undersigned.
|
DEERFIELD CAPITAL, L.P.
|
||
|
By:
|
J.E. Flynn Capital LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
DEERFIELD PARTNERS, L.P.
|
||
|
By:
|
Deerfield Capital, L.P.
|
|
|
By:
|
J.E. Flynn Capital LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
|
<
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Darren Levine, Attorney-In-Fact
|
|
|
DEERFIELD MANAGEMENT COMPANY, L.P.
|
||
|
By:
|
Flynn Management LLC,
General Partner
|
|
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
DEERFIELD INTERNATIONAL LIMITED
|
||
|
By:
|
/s/ Darren Levine
|
|
|
Darren Levine, Attorney-In-Fact
|
||
|
JAMES E. FLYNN
|
||
|
/s/ Darren Levine
|
||
|
Darren Levine, Attorney-In-Fact
|
||
Exhibit B
Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.